dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Gorbatenko, Andrej |
dc.contributor.author | Søkilde, Rolf |
dc.contributor.author | Sorensen, Ester E. |
dc.contributor.author | Newie, Inga |
dc.contributor.author | Persson, Helena |
dc.contributor.author | Morancho Armisen, Beatriz |
dc.contributor.author | Arribas López, Joaquin Vicente |
dc.date.accessioned | 2021-04-20T11:30:02Z |
dc.date.available | 2021-04-20T11:30:02Z |
dc.date.issued | 2019-03-04 |
dc.identifier.citation | Gorbatenko A, Søkilde R, Sorensen EE, Newie I, Persson H, Morancho B, et al. HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503. Sci Rep. 2019 Mar 4;9(1):3352. |
dc.identifier.issn | 2045-2322 |
dc.identifier.uri | https://hdl.handle.net/11351/5878 |
dc.description | Mecanismes de la malaltia; Càncer de mama |
dc.description.sponsorship | This work was supported by the Danish Council for Independent Research (grants no. 12-126942 and 12-127290 to SFP), by the Hartmann foundation (SFP), Fondation Juchum (SFP), Kirsten og Freddy Johansens Fond (SFP), the Breast Cancer Research Foundation (BCRF-17-008) (JA), Instituto de Salud Carlos III (PI16/00253) (JA) and the Harboe foundation (SFP). Katrine Franklin Mark is gratefully acknowledged for excellent technical assistance. We are grateful to Pascal Pineau from Institut Pasteur, France for the MYBL1 3′UTR/psiCHECK2 construct. |
dc.language.iso | eng |
dc.publisher | Nature Publishing Group |
dc.relation.ispartofseries | Scientific Reports;9(1) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer |
dc.subject | Cèl·lules canceroses |
dc.subject.mesh | Breast Neoplasms |
dc.subject.mesh | MCF-7 Cells |
dc.title | HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503 |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41598-019-39733-x |
dc.subject.decs | neoplasias de la mama |
dc.subject.decs | células MCF-7 |
dc.relation.publishversion | https://www.nature.com/articles/s41598-019-39733-x |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Gorbatenko A] Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, 10029, USA. [Søkilde R, Newie I, Persson H] BioCare, Strategic Cancer Research Program, Lund, Sweden. Department of Clinical Sciences Lund, Oncology and Pathology, Faculty of Medicine, Lund University, Lund, Sweden. [Sorensen EE] Section for Cell Biology and Physiology, Department of Biology, Faculty of Science, University of Copenhagen, Universitetsparken 13, DK-2100, Copenhagen, Denmark. [Morancho B] Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. CIBERONC. [Arribas J] Preclinical Research Program, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. CIBERONC. Departament de Bioquímica i de Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain. Institució Catalana de Recerca i Estudis Avançats, JA, Barcelona, Spain |
dc.identifier.pmid | 30833639 |
dc.identifier.wos | 000460123600024 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F00253 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |